Company overview
FUJIFILM Biosciences is a global life sciences media provider offering innovative products and contract development and manufacturing organization (CDMO) services for biopharmaceutical development and commercialization. The company operates state-of-the-art facilities across the USA, Japan, and Europe with capabilities spanning early-stage research through commercial manufacturing of therapeutics and vaccines. FUJIFILM provides redundant manufacturing capacity, quality control laboratories, and cold-chain logistics to support regulated product development with FDA and ISO compliance.
Irvinesci Com is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include cdmo contract manufacturing, biopharmaceutical manufacturing, cell culture media, fda compliant facilities, therapeutic manufacturing.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://fujifilmbiosciences.fujifilm.com/us/
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- cdmo contract manufacturing, biopharmaceutical manufacturing, cell culture media, fda compliant facilities, therapeutic manufacturing
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What manufacturing capabilities does FUJIFILM Biosciences offer?
- FUJIFILM Biosciences operates redundant powder and liquid manufacturing suites across three continents (USA, Japan, and Netherlands). The company provides scalable manufacturing technology, dedicated animal component-free manufacturing, and large-scale bioreactor capacity including 8 20,000-liter bioreactors at the Holly Springs, North Carolina facility. Services span from early development through commercial production of drug substances and drug products.
- What are FUJIFILM's global facility locations and capabilities?
- FUJIFILM operates facilities in Santa Ana, California (corporate headquarters with liquid/powder manufacturing, R&D, and quality control); Tokyo, Japan (powder manufacturing with complete redundancy systems); Billingham Teesside, UK (212,200-ft² expansion); Holly Springs, North Carolina (1.5 million-ft² large-scale facility with Phase 1 operational since September 2025); and Toyama, Japan (16,000-m² site for small/mid-scale and antibody drug conjugate manufacturing, operational in 2027). Worldwide warehousing and distribution centers support consistent supply.
- What regulatory standards and quality practices does FUJIFILM maintain?
- FUJIFILM Biosciences conforms to FDA and International Organization for Standardization (ISO) standards with comprehensive validation, qualification, and certification of methods, equipment, and processes. The company uses multi-compendial grade components, Water For Injection (WFI) tested per USP requirements, and maintains industry-leading supply chain management and sourcing strategies to ensure consistent, reliable product delivery.
Related editorial coverage
- DuPont Launches AmberChrom XT SL Chromatography Resins to Streamline Biopharmaceutical Manufacturing
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
